Achieve Life Sciences ACHV Institutional Ownership

Updated Oct 11, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) was reported as a holding by 113 institutional investors in 13F filings for the quarter ended June 30, 2026.

• Their combined stake equaled 80.40% of outstanding shares in Q2 2026, up from 40.32% in Q1 2026.
• Total holdings of ACHV shares rose 283.69% from Q1 2026, and the holder count rose 85.25% from Q2 2025.
• Among the 113 holders of Achieve Life Sciences, 86 added to their positions, 14 reduced their stakes and 13 left their positions unchanged.
• In total, institutional investors held 82.59Mn shares of Achieve Life Sciences at the end of Q2 2026, up 61.06Mn from the prior quarter and up 56.51Mn from a year earlier.
• Frazier Life Sciences Management, L.P. was the top holder of Achieve Life Sciences as of June 30, 2026, with 7.61Mn shares, or 7.41% of shares outstanding.
• Among holders that already owned Achieve Life Sciences, the biggest buyers in Q2 2026 were BlackRock, Inc. (+4.83Mn shares), Marshall Wace, LLP (+2.75Mn shares), State Street Corp (+2.69Mn shares), Vanguard Capital Management LLC (+1.94Mn shares) and Geode Capital Management, LLC (+1.44Mn shares).
• The largest position reductions in ACHV for Q2 2026 were by Susquehanna International Group, LLP (-353.31K shares), Two Sigma Investments, LP (-147.36K shares), Jane Street Group, LLC (-126.14K shares), Shay Capital LLC (-112.3K shares) and Goldman Sachs Group Inc (-111.98K shares).
• According to Business Quant data, the leading holders of ACHV for Q2 2026 were Frazier Life Sciences Management, L.P. (7.61Mn shares), TPG GP A, LLC (6.88Mn shares), venBio Partners LLC (5.91Mn shares), Logos Global Management LP (5.42Mn shares), BlackRock, Inc. (5.27Mn shares), Franklin Templeton Inc (4.95Mn shares), Paradigm Biocapital Advisors LP (4.95Mn shares), Vanguard Capital Management LLC (4.14Mn shares), Propel Bio Management, LLC (4.03Mn shares) and Marshall Wace, LLP (3.77Mn shares).